← Browse by Condition
Medical Condition

b cell non hodgkins lymphoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06806033 Phase 2
Recruiting

A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed/Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma

Enrollment
100 pts
Location
United States, Austr...
Sponsor
Hoffmann-La Roche
View Trial →